Department of Ophthalmology, Rabin Medical Center, Petah-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Curr Eye Res. 2021 Oct;46(10):1460-1466. doi: 10.1080/02713683.2021.1899245. Epub 2021 Apr 11.
: To evaluated Descemet's membrane endothelial keratoplasty (DMEK) outcomes in young and old graft recipients.: Data of 164 surgeries with a median age of 76 years (interquartile range 14 years) undergoing DMEK surgery between 2016 and 2018 was reviewed. Complications, graft survival, and visual acuity gain were compared between subjects in the 25th percentile (young recipients; aged 70 years and less, n = 21) and 75th percentile (old recipients; aged 85 years and over, n = 27) over the 2-year follow-up.: Young recipients had a lower rate of pre-operative glaucoma (14.3% vs. 51.9%, = .014) and pseudophakic bullous keratopathy (9.5% vs. 59.3%, < .001), and a higher rate of Fuchs endothelial dystrophy (57.1% vs. 14.8%, = .002) and combined cataract extraction at the time of DMEK surgery (52.4% vs. 7.4%, = .001) when compared to old recipients. Complications (primary graft failure, pupillary block, cystoid macular edema or infectious keratitis) were independent of graft recipient age. Descemet's membrane detachment requiring re-bubbling was observed more often in young compared to the old recipients (42.9% vs. 14.8%, = .049). Visual acuity gain between the groups remained comparable up to 1-year, whereas at 2-years old recipients showed significantly declined visual acuity gains compared to the young recipients (0.14 ± 0.68 vs. 0.74 ± 0.49, = .012). Graft recipients aged over 85 years had a considerably higher graft failure rate over the 24-months (40.7% vs. 4.8%, = .006) and shorter graft survival time ( = .002; log-rank) when compared to the recipients aged under 70 years. After adjusting for potential confounders such as Fuchs endothelial dystrophy, pseudophakic bullous keratopathy and glaucoma, the recipients aged over 85 remained at higher risk for graft failure (HR = 17.278, 95% CI = 1.787-167.1, = .014).: In aged DMEK recipients, regardless of the low incidence of early postoperative complications, the rate of postoperative graft failure was significantly higher and graft survival shorter than in younger recipients.
: 评估年轻和老年供体接受的 Descemet 膜内皮角膜移植术 (DMEK) 的结果。: 回顾了 2016 年至 2018 年间接受 DMEK 手术的 164 例手术的数据,中位年龄为 76 岁(四分位距 14 岁)。在 2 年的随访中,比较了 25%分位数(年轻供体;年龄 70 岁及以下,n = 21)和 75%分位数(老年供体;年龄 85 岁及以上,n = 27)的受试者之间的并发症、移植物存活率和视力提高情况。: 年轻供体术前青光眼的发生率较低(14.3% vs. 51.9%, =.014)和假性囊泡性角膜病变(9.5% vs. 59.3%, <.001),而 Fuchs 内皮营养不良(57.1% vs. 14.8%, =.002)和白内障联合切除在 DMEK 手术时的发生率较高(52.4% vs. 7.4%, =.001)与老年供体相比。并发症(原发性移植物失功、瞳孔阻滞、囊样黄斑水肿或感染性角膜炎)与移植物供体年龄无关。与老年供体相比,年轻供体中需要重新鼓泡的 Descemet 膜脱离更为常见(42.9% vs. 14.8%, =.049)。两组之间的视力提高在 1 年内保持相当,但在 2 年内,老年供体的视力提高明显低于年轻供体(0.14 ± 0.68 vs. 0.74 ± 0.49, =.012)。与 70 岁以下的供体相比,85 岁以上的供体在 24 个月内移植物失功率显著更高(40.7% vs. 4.8%, =.006),移植物存活率更短( =.002;对数秩)。在调整了 Fuchs 内皮营养不良、假性囊泡性角膜病变和青光眼等潜在混杂因素后,85 岁以上的供体发生移植物失功的风险仍然更高(HR = 17.278,95%CI = 1.787-167.1, =.014)。: 在老年 DMEK 受者中,尽管术后早期并发症发生率较低,但移植物失功的发生率明显高于年轻受者,移植物存活率也较短。